跳至主要内容
临床试验/NCT07146308
NCT07146308已完成不适用

Multiscale Causal Disease Warning and Assisted Diagnosis: Multi-omics Mechanisms of Lifestyle Intervention in Regulating Blood Glucose

Shanghai 6th People's Hospital1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2025年8月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
61
试验地点
1
主要终点
Post-intervention incremental area under the glucose curve (iAUC) measured by continuous glucose monitoring (CGM)

研究概览

简要总结

The mechanisms by which lifestyle interventions regulate blood glucose remain incompletely understood. Traditional research has predominantly focused on single targets or pathways, making it difficult to comprehensively elucidate the complex biological regulatory networks. This study systematically investigates the effects of lifestyle interventions on blood glucose and explores their molecular mechanisms. Through integrated multi-omics analysis-including genomics, proteomics, metabolomics, and microbiomics-investigators aim to identify key biological pathways and molecular targets through which dietary, exercise, and other lifestyle interventions influence glucose regulation, as well as discover biomarkers that reflect the efficacy of these interventions. Building upon these findings, investigators will establish a multi-omics molecular network model linking lifestyle interventions to glucose regulation and develop an auxiliary decision-making system for personalised diabetes diagnosis and treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Aged 18-70 years

排除标准

  • •Severe chronic diabetic complications or recent acute diabetic complications
  • •Type 1 diabetes mellitus
  • •Early-onset diabetes
  • •Patients currently using insulin therapy
  • •Recent severe hypoglycemic episodes
  • •Secondary obesity
  • •Pregnancy, severe hepatic/renal diseases, thyroid disorders, acute infections, psychiatric disorders, or other conditions that may interfere with study outcomes

研究组 & 干预措施

Lifestyle intervention Arm

Experimental

干预措施: Lifestyle Management (Other)

结局指标

主要结局

Post-intervention incremental area under the glucose curve (iAUC) measured by continuous glucose monitoring (CGM)

时间窗: 4 weeks

次要结局

  • Proteomics profiling(Baseline and 4 weeks)
  • Fecal Metagenomics(Baseline and 4 weeks)
  • Fecal Metabolomics(Baseline and 4 weeks)
  • Lipidomics profiling(Baseline and 4 weeks)
  • Time in Range (TIR), Time Above Range (TAR), Time Below Range (TBR) Measured by Continuous Glucose Monitoring(Baseline and 4 weeks)
  • Composite glucose metabolism profile(Baseline and 4 weeks)
  • Composite kidney function profile(Baseline and 4 weeks)
  • Composite liver function profile(Baseline and 4 weeks)
  • Lipid profile(Baseline and 4 weeks)
  • Inflammatory markers(Baseline and 4 weeks)
  • Retinopathy status (digital retinal fundus imaging)(Baseline and 4 weeks)
  • Number of sets and repetitions(Each exercise session, aggregated daily up to 28 days)
  • Composite dietary intake profile(At each meal, aggregated dayly, up to 28 days)
  • Composite physiological monitoring profile from wearables(Daily measurements, up to 28 days)
  • Lifestyle management-related parameters(Baseline and 4 weeks)
  • Complete Blood Count(Baseline and 4 weeks)
  • Routine urine test(Baseline and 4 weeks)
  • Mean Glucose measured by continuous glucose monitoring(Baseline and 4 weeks)
  • Glucose Variability measured by continuous glucose monitoring(Baseline and 4 weeks)
  • Area Under the Curve (AUC) measured by continuous glucose monitoring(Baseline and 4 weeks)
  • Body weight(Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks)
  • Height(Baseline)
  • BMI(Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks)
  • Waist, hip and thigh circumference(Baseline, 4 weeks)
  • Systolic and Diastolic Blood Pressure(Baseline, 4 weeks)
  • Resting heart rate(Baseline, 4 weeks)
  • Genomic profiling(Baseline and 4 weeks)
  • Metabolomics profiling(Baseline and 4 weeks)
  • PBMC Multi-omics Profiling(Baseline and 4 weeks)
  • Glycemic Excursions Composite Score from Continuous Glucose Monitoring(Baseline and 4 weeks)
  • Exercise heart rate(Each exercise session, aggregated daily up to 28 days)
  • Exercise frequency(Each exercise session, aggregated daily up to 28 days)
  • Energy expenditure per session(Each exercise session, aggregated daily up to 28 days)
  • Exercise duration(Each exercise session, aggregated daily up to 28 days)
  • Exercise intensity/load(Each exercise session, aggregated daily up to 28 days)
  • Excess post-exercise oxygen consumption(Each exercise session, aggregated daily up to 28 days)
  • Fat mass(Baseline, 1 week, 2 week, 3 week, 4 week)
  • Fat-free mass(Baseline, 1 week, 2 week, 3 week, 4 week)
  • Body fat percentage(Baseline, 1 week, 2 week, 3 week, 4 week)
  • Visceral fat area(Baseline, 1 week, 2 week, 3 week, 4 week)
  • Muscle mass(Baseline, 1 week, 2 week, 3 week, 4 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Li Huating

Professor

Shanghai 6th People's Hospital

研究点 (1)

Loading locations...

相似试验